(Q41495778)

1 October 2017

1 reference

title

Viral hepatitis in older adults (English)

1 reference

1 October 2017

1 reference

Marcus EL

1

1 reference

1 October 2017

Tur-Kaspa R

series ordinal

2

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

Journal of the American Geriatrics Society

1 October 2017

published in

1 reference

1 October 2017

volume

45

1 reference

1 October 2017

issue

6

1 reference

1 October 2017

page(s)

755-763

1 reference

Alphabet of hepatitis viruses

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Immunology of viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Isolation of novel virus-like sequences associated with human hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

The cloning and clinical implications of HGV and HGBV-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Hepatitis in nursing homes. Incidence and management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

History and epidemiology of hepatitis A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Age-specific antibody prevalence to hepatitis A in England: implications for disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Epidemiology of hepatitis A in Mediterranean countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Evidence of Prior Hepatitis B and Hepatitis A Virus Infections in an Ambulatory Geriatric Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Clinical experience with an inactivated hepatitis A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Prevention of acute and chronic liver disease through immunization: hepatitis B and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Non A, non B hepatitis in the aged

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Hepatitis B and the HB-SAg carrier. An outbreak related to sexual contact

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Hepatitis B virus infection in homes for the aged

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

High carrier rate after hepatitis B virus infection in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Are homes for the elderly still a risk area for HBV infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Anti-hepatitis C virus in the elderly: a seroepidemiological study in a home for the aged

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Prevalence of hepatitis B surface antigen, hepatitis C antibody, and HIV-1 antibody among residents of a long-term-care facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Hepatitis C virus infection among elderly patients in a geriatric hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Seroepidemiology of hepatitis B virus infection in the United States. 1976 to 1980.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Comprehensive control (or elimination) of hepatitis B virus transmission in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Multivariate analysis of prognostic factors in fulminant hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Hepatitis B virus. The major etiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Hepatitis B vaccine responsiveness in Connecticut public safety personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Hepatitis B virus vaccination for older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Interferon therapy for patients more than 60 years of age with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Epidemiology of Hepatitis C in the West

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Prevalence of hepatitis C virus antibodies in Italian blood donors. The Italian Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Prevalence of anti-HCV antibody in blood donors in the Tokyo area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Prevalence of hepatitis C virus antibodies and hepatitis C virus-RNA in an urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Infection with hepatitis GB virus C in patients on maintenance hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Hepatitis C virus: epidemiology and genotypes in the north east of England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

21 January 2018

Therapy of Hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Treatment of Hepatitis C Virus in Elderly Persons With Interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Interferon treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Two years' investigation of epidemic hepatitis E virus transmission in West Kalimantan (Borneo), Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Risk factors and prevalence of hepatitis E in German immigrants from the former Soviet Union

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Hepatitis GB virus C in patients on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Effect of hepatitis G virus infection on chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Hepatitis G virus infection: a work in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1997.TB01484.X

10.1111/J.1532-5415.1997.TB01484.X

21 January 2018

Identifiers

DOI

1 reference

1 October 2017

1 reference